This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
CHARLESTON, W.Va. (AP) — As a pharmaceutical company run by U.S. Sen. Joe Manchin's daughter faces scrutiny for hiking prices on life-saving allergy injection pens, Manchin is remaining mum.
The Democratic West Virginia senator's daughter, Heather Bresch, is CEO of Mylan, which manufactures EpiPens.
A two-dose package cost around $94 nine years ago. The cost averaged more than six times that in May.
Manchin spokesman Jonathan Kott said Wednesday the senator had no comment.
Several senators are demanding more information and requesting congressional hearings and investigations.
Sens. Amy Klobuchar of Minnesota and Richard Blumenthal of Connecticut want the Federal Trade Commission to investigate Mylan for possible antitrust violations.
Hillary Clinton, whom Manchin has endorsed for president, called the increase "outrageous."
A Mylan statement Monday cited health insurance changes with higher deductible costs for many.
This story has been corrected to say that Mylan statement was issued Monday, not Tuesday. Will be updated.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.